Evidence map›Paper›PMID 22886787›Full record

ArticleArthritis and rheumatism2012

Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations.

Elena Sánchez, Astrid Rasmussen, Laura Riba, Eduardo Acevedo-Vasquez, Jennifer A Kelly, Carl D Langefeld, Adrianne H Williams, Julie T Ziegler, Mary E Comeau, Miranda C Marion and 44 more

Open access · bronzeAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Lupus in Latin America: Where are we now?Clinical rheumatology · 2026
    Article
  4. Article
  5. Towards precision medicine for systemic lupus erythematosus and neuropsychiatric manifestations.Expert review of precision medicine and drug development · 2025
    Article
  6. Does the esv3587290 Copy Number Variation in theChildren (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Article
  9. Transcriptome Studies in Lupus Nephritis.Archivum immunologiae et therapiae experimentalis · 2022
    Review
  10. Review
  11. Observational
  12. Review
  13. Article
  14. Article
  15. New Attempts to Define and Clarify Lupus.Current rheumatology reports · 2019
    Review
  16. Article
  17. Genetics and genomics in Peru: Clinical and research perspective.Molecular genetics & genomic medicine · 2018
    Review
  18. Article
  19. Genetics of human lupus nephritis.Clinical immunology (Orlando, Fla.) · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

54 authors at 20 institutions in 9 countries.

Elena SánchezOklahoma Medical Research Foundation, Oklahoma City, USA.
Astrid Rasmussen
Laura Riba
Eduardo Acevedo-Vasquez
Jennifer A Kelly
Carl D Langefeld
Adrianne H Williams
Julie T Ziegler
Mary E Comeau
Miranda C Marion
Ignacio García-De La Torre
Marco A Maradiaga-Ceceña
Mario H Cardiel
Jorge A Esquivel-Valerio
Jacqueline Rodriguez-Amado
José Francisco Moctezuma
Pedro Miranda
Carlos E Perandones
Cecilia Castel
Hugo A Laborde
Paula Alba
Jorge L Musuruana
I Annelise Goecke
Juan-Manuel Anaya
Kenneth M Kaufman
Adam Adler
Stuart B Glenn
Elizabeth E Brown
Graciela S Alarcón
Robert P Kimberly
Jeffrey C Edberg
Luis M Vilá
Lindsey A Criswell
Gary S Gilkeson
Timothy B Niewold
Javier Martín
Timothy J Vyse
Susan A Boackle
Rosalind Ramsey-Goldman
R Hal Scofield
Michelle Petri
Joan T Merrill
John D Reveille
Betty P Tsao
Lorena Orozco
Vicente Baca
Kathy L Moser
Patrick M Gaffney
Judith A James
John B Harley
Teresa Tusié-Luna
Bernardo A Pons-Estel
Chaim O Jacob
Marta E Alarcón-Riquelme
Oklahoma Medical Research Foundation · USWake Forest University · USInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXUniversidad Nacional Autónoma de México · MXUniversity of Alabama at Birmingham · USHospital Base Guillermo Almenara Irigoyen · PEUniversity of Oklahoma · USCincinnati Children's Hospital Medical Center · USUniversidad Autónoma de Nuevo León · MXConsejo Superior de Investigaciones Científicas · ESJohns Hopkins University · USKing's College London · GBMedical University of South Carolina · USMexican Social Security Institute · MXNorthwestern University · USThe University of Texas at Austin · USUniversidad del Rosario · COUniversity of Buenos Aires · ARUniversity of California, Los Angeles · USUniversity of California, San Francisco · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
U OF TEXAS HLTH SCI CTR HOUSTON CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCESUL1RR024148 · NCRR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2006 to 2010
$27.9M
MULTIDISCIPLINARY CLINICAL AND TRANSLATIONAL SCIENCE (MCTS) PROGRAM (UL1)UL1RR025741 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GREENLAND, PHILIP · 2008 to 2011
$24.7M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
Program Project in the Genetics of SLEP01AR049084 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2002 to 2012
$12.7M
The Interplay of Sociodemographic and Genetic Factors in SLE Health DisparitiesP60AR053308 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YELIN, EDWARD H · 2006 to 2016
$11.8M
Multidisciplinary Clinical and Translational Science (MCTS) Program (UL1)UL1TR000150 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LLOYD-JONES, DONALD M · 2012 to 2013
$10.1M
SequencingP01AI083194 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KIMBERLY, ROBERT P. · 2009 to 2013
$9.6M
Lupus CohortR01AR043727 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI PETRI, MICHELLE A · 1997 to 2015
$8.2M
HLA GENE COMPLEMENTATION IN PRIMARY SJOGREN'S AND LUPUSR01AI024717 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KOTTYAN, LEAH CLAIRE, WEIRAUCH, MATTHEW TYSON · 1987 to 2025
$7.8M
SNP Confirmation and High Throughput Genotyping CoreP30AR053483 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI CHAKRAVARTY, ELIZA F · 2007 to 2017
$6.7M
NCATS NIH HHS UL1 TR000150NCATS NIH HHS UL1 TR000154NCI NIH HHS P30 CA046934NCRR NIH HHS P30 RR031152NCRR NIH HHS P30-RR-031152NCRR NIH HHS UL1 RR024148NCRR NIH HHS UL1 RR025005NCRR NIH HHS UL1-RR-025005NCRR NIH HHS UL1 RR025741NCRR NIH HHS UL1-RR-025741NIAID NIH HHS K24 AI078004NIAID NIH HHS P01 AI083194NIAID NIH HHS P01-AI-083194NIAID NIH HHS R01 AI024717NIAID NIH HHS R21 AI070304NIAID NIH HHS R21-AI-070304NIAID NIH HHS R37 AI024717NIAMS NIH HHS AR-43727NIAMS NIH HHS K24 AR002138NIAMS NIH HHS K24-AR-002138NIAMS NIH HHS P01 AR049084NIAMS NIH HHS P01-AR-49084NIAMS NIH HHS P30 AR053483NIAMS NIH HHS P30-AR-053483NIAMS NIH HHS P60 2-AR-30692NIAMS NIH HHS P60 AR030692NIAMS NIH HHS P60 AR053308NIAMS NIH HHS P60-AR-053308NIAMS NIH HHS P60 AR062755NIAMS NIH HHS R01 AR043727NIAMS NIH HHS R01 AR052300NIAMS NIH HHS R01-AR-052300NIAMS NIH HHS R01 AR057172NIAMS NIH HHS RC1 AR058621NIGMS NIH HHS 8 P20-GM-103456-09NIGMS NIH HHS P20 GM103456
6 · The paper itself

Abstract

objectiveAmerican Indian-Europeans, Asians, and African Americans have an excess morbidity from systemic lupus erythematosus (SLE) and a higher prevalence of lupus nephritis than do Caucasians. The aim of this study was to analyze the relationship between genetic ancestry and sociodemographic characteristics and clinical features in a large cohort of American Indian-European SLE patients.

methodsA total of 2,116 SLE patients of American Indian-European origin and 4,001 SLE patients of European descent for whom we had clinical data were included in the study. Genotyping of 253 continental ancestry-informative markers was performed on the Illumina platform. Structure and Admixture software were used to determine genetic ancestry proportions of each individual. Logistic regression was used to test the association between genetic ancestry and sociodemographic and clinical characteristics. Odds ratios (ORs) were calculated with 95% confidence intervals (95% CIs).

resultsThe average American Indian genetic ancestry of 2,116 SLE patients was 40.7%. American Indian genetic ancestry conferred increased risks of renal involvement (P < 0.0001, OR 3.50 [95% CI 2.63- 4.63]) and early age at onset (P < 0.0001). American Indian ancestry protected against photosensitivity (P < 0.0001, OR 0.58 [95% CI 0.44-0.76]), oral ulcers (P < 0.0001, OR 0.55 [95% CI 0.42-0.72]), and serositis (P < 0.0001, OR 0.56 [95% CI 0.41-0.75]) after adjustment for age, sex, and age at onset. However, age and sex had stronger effects than genetic ancestry on malar rash, discoid rash, arthritis, and neurologic involvement.

conclusionIn general, American Indian genetic ancestry correlates with lower sociodemographic status and increases the risk of developing renal involvement and SLE at an earlier age.

Indexed as

AdolescentAdultChildFemaleGenetic Predisposition to DiseaseGenotypeHumansIndians, North AmericanIndians, South AmericanLupus Erythematosus, SystemicLupus NephritisMaleMiddle AgedMorbidityPrevalenceRisk Factors

Identifiers

PMID22886787
PMCPMC3485439
OpenAlexW2086713511

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.